Source: Medivolve Inc.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Medivolve Inc. (MEDV) is considering expanding its network of mobile COVID-19 testing centres in anticipation of another COVID wave fueled by the BA.4 and BA.5 subvariants
  • Its wholly owned subsidiary, Collection Sites LLC. has a network of 22 mobile COVID-19 testing centres across the U.S.
  • Each site is a modular pod “cube” licensed by a lab certified by the United States Government Department of Health and Human Services
  • Medivolve (MEDV) was trading steady at $0.045 a share as of 4:15 pm ET

Medivolve (MEDV) is considering expanding its network of mobile COVID-19 testing centres in anticipation of another COVID wave fueled by the BA.4 and BA.5 subvariants.

The Toronto-based company recently updated its business, primarily conducted through its wholly owned subsidiary, Collection Sites LLC.

Collection Sites has a network of 22 mobile COVID-19 testing centres across the U.S.

Each site is a modular pod “cube” licensed by a lab certified by the United States Government Department of Health and Human Services.

Medivolve’s CEO, David Preiner commented that COVID-19 testing is still an important detection and tool to fight the ongoing pandemic.

“Governments around the world have lifted restrictions and reduced coronavirus tracking as they grapple with pandemic fatigue, however new waves of the virus demonstrate that COVID-19 is nowhere near over. Medivolve is proud of its work to continue to offer COVID testing to citizens throughout the United States.”

The company is also looking to open more testing centres in underserved neighbourhoods.

Medivolve Inc. (MEDV) is a healthcare technology company that seeks to reinvent the US healthcare system by leveraging a bespoke telehealth platform, a clinical diagnostic network, and a data-driven AI framework to improve patient care.

Medivolve (MEDV) was trading steady at $0.045 a share as of 4:14 pm ET.


More From The Market Herald

" Plurilock’s (TSXV:PLUR) Aurora System receives US$3 million in purchase orders

Plurilock’s (PLUR) subsidiary, Aurora Systems Consulting, received purchase orders from several organizations in July 2022, totalling US$2,984,599.
The Market Herald Video

" Datametrex AI Limited (TSXV:DM) introduces the mobile charging cart

Datametrex AI (DM) subsidiary, Datametrex Electric Vehicle Solutions (DM EVS) is introducing the mobile charging cart to commercial spaces in Vancouver.
Medicenna - President and CEO, Fahar Merchant.

" Medicenna (TSX:MDNA) closes US$20 million public offering

Medicenna Therapeutics Corp. (MDNA) has closed its

" Titan Medical (TSX:TMD) reports Q2 2022 financial results

Titan Medical (TMD) released financial results for the three and six months ended June 30, 2022.